These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24766367)

  • 1. Economic challenges associated with tuberculosis diagnostic development.
    Hanrahan CF; Shah M
    Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):499-510. PubMed ID: 24766367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Market assessment of tuberculosis diagnostics in Brazil in 2012.
    TB Diagnostics Market Analysis Consortium
    PLoS One; 2014; 9(8):e104105. PubMed ID: 25099237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New diagnostics for tuberculosis: fulfilling patient needs first.
    Lemaire JF; Casenghi M
    J Int AIDS Soc; 2010 Oct; 13():40. PubMed ID: 20973946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operational modelling to guide implementation and scale-up of diagnostic tests within the health system: exploring opportunities for parasitic disease diagnostics based on example application for tuberculosis.
    Langley I; Adams E; Doulla B; Squire SB
    Parasitology; 2014 Dec; 141(14):1795-802. PubMed ID: 25035934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools.
    Lin HH; Langley I; Mwenda R; Doulla B; Egwaga S; Millington KA; Mann GH; Murray M; Squire SB; Cohen T
    Int J Tuberc Lung Dis; 2011 Aug; 15(8):996-1004. PubMed ID: 21740663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects.
    Pai M; Schito M
    J Infect Dis; 2015 Apr; 211 Suppl 2(Suppl 2):S21-8. PubMed ID: 25765103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TB diagnostic tests: how do we figure out their costs?
    Sohn H; Minion J; Albert H; Dheda K; Pai M
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):723-33. PubMed ID: 19681700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings.
    Sabiiti W; Mtafya B; Kuchaka D; Azam K; Viegas S; Mdolo A; Farmer EC; Khonga M; Evangelopoulos D; Honeyborne I; Rachow A; Heinrich N; Ntinginya NE; Bhatt N; Davies GR; Jani IV; McHugh TD; Kibiki G; Hoelscher M; Gillespie SH;
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1004-9. PubMed ID: 27393531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.
    Dowdy DW; O'Brien MA; Bishai D
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1021-9. PubMed ID: 18713499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.
    Engel N; Ochodo EA; Karanja PW; Schmidt BM; Janssen R; Steingart KR; Oliver S
    Cochrane Database Syst Rev; 2022 Apr; 4(4):CD014877. PubMed ID: 35470432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis.
    Foster N; Cunnama L; McCarthy K; Ramma L; Siapka M; Sinanovic E; Churchyard G; Fielding K; Grant AD; Cleary S
    PLoS One; 2021; 16(5):e0251547. PubMed ID: 33989317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public health costs for tuberculosis suspects in Wake County, North Carolina, United States.
    Park PH; Holland DP; Wade A; Goswami ND; Bissette D; Stout JE
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):759-63. PubMed ID: 23676158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs of novel tuberculosis diagnostics--will countries be able to afford it?
    Pantoja A; Kik SV; Denkinger CM
    J Infect Dis; 2015 Apr; 211 Suppl 2():S67-77. PubMed ID: 25765108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis: lights and shadows in the current diagnostic landscape.
    Norbis L; Miotto P; Alagna R; Cirillo DM
    New Microbiol; 2013 Apr; 36(2):111-20. PubMed ID: 23686117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis remains a challenge despite economic growth in Panama.
    Tarajia M; Goodridge A
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):286-8. PubMed ID: 24670562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global-to-local policy transfer in the introduction of new molecular tuberculosis diagnostics in South Africa.
    Colvin CJ; Leon N; Wills C; van Niekerk M; Bissell K; Naidoo P
    Int J Tuberc Lung Dis; 2015 Nov; 19(11):1326-38. PubMed ID: 26467585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How affordable are tuberculosis diagnosis and treatment in rural China? An analysis from community and tuberculosis patient perspectives.
    Liu X; Thomson R; Gong Y; Zhao F; Squire SB; Tolhurst R; Zhao X; Yan F; Tang S
    Trop Med Int Health; 2007 Dec; 12(12):1464-71. PubMed ID: 18076553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis.
    Dowdy DW; Andrews JR; Dodd PJ; Gilman RH
    Elife; 2014 Jun; 3():. PubMed ID: 24898755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid implementation of new TB diagnostic tests: is it too soon for a global roll-out of Xpert MTB/RIF?
    Kirwan DE; Cárdenas MK; Gilman RH
    Am J Trop Med Hyg; 2012 Aug; 87(2):197-201. PubMed ID: 22855746
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.